{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:46:40Z","timestamp":1782182800292,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.amjms.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:48:59Z","timestamp":1739360939000},"page":"613-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance"],"prefix":"10.1016","volume":"369","author":[{"given":"Katlyn M.","family":"Smaha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N.","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"Bollag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2025.02.007_bib0001","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12016-021-08859-0","article-title":"Current perspectives on severe drug eruption","volume":"61","author":"Zhang","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2025.02.007_bib0002","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.amjms.2025.02.007_bib0003","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Gutan Med Surg"},{"issue":"1","key":"10.1016\/j.amjms.2025.02.007_bib0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens\u2013Johnson Syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"23","key":"10.1016\/j.amjms.2025.02.007_bib0005","doi-asserted-by":"crossref","first-page":"9101","DOI":"10.3390\/ijerph17239101","article-title":"Impact of adverse drug reactions in patients with end stage renal disease in Greece","volume":"17","author":"Spanakis","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.amjms.2025.02.007_bib0006","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11882-018-0778-6","article-title":"Severe cutaneous adverse drug reactions: presentation, risk factors, and management","volume":"18","author":"Mustafa","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.amjms.2025.02.007_bib0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mjafi.2013.01.007","article-title":"Severe cutaneous adverse drug reactions","volume":"69","author":"Verma","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.amjms.2025.02.007_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdin.2023.06.014","article-title":"Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome","volume":"13","author":"Wasuwanich","year":"2023","journal-title":"JAAD Int"},{"issue":"6","key":"10.1016\/j.amjms.2025.02.007_bib0009","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjms.2025.02.007_bib0010","series-title":"2021 USRDS annual data report: epidemiology of kidney disease in the United States","year":"2021"},{"issue":"12","key":"10.1016\/j.amjms.2025.02.007_bib0011","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.amjms.2025.02.007_bib0012","first-page":"188","article-title":"Charlson Comorbidity Index: iCD-9Update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"2","key":"10.1016\/j.amjms.2025.02.007_bib0013","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.amjms.2025.02.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: a literature review and treatment algorithm","volume":"16","author":"Calle","year":"2023","journal-title":"World Allergy Organ J"},{"issue":"5","key":"10.1016\/j.amjms.2025.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2025.02.007_bib0016","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2025.02.007_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajic.2003.05.007","article-title":"Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients","volume":"32","author":"Taylor","year":"2004","journal-title":"Am J Infect Control"},{"issue":"4","key":"10.1016\/j.amjms.2025.02.007_bib0018","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3400\/avd.oa.22-00058","article-title":"Management of arteriovenous graft infection","volume":"15","author":"Hisata","year":"2022","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.amjms.2025.02.007_bib0019","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2012.10894.x","article-title":"Association between HLA-B58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong","volume":"167","author":"Chiu","year":"2012","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2025.02.007_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40360-020-00464-9","article-title":"Common causes and characteristics of adverse drug reactions in older adults: a retrospective study","volume":"21","author":"Woo","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.amjms.2025.02.007_bib0021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdin.2022.12.002","article-title":"Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database","volume":"11","author":"Ubukata","year":"2022","journal-title":"JAAD Int"},{"issue":"2","key":"10.1016\/j.amjms.2025.02.007_bib0022","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semarthrit.2016.03.014","article-title":"Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States","volume":"46","author":"Lu","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.amjms.2025.02.007_bib0023","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0884533616642746","article-title":"Nutrition in toxic epidermal necrolysis: a multicenter review","volume":"31","author":"Graves","year":"2016","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.amjms.2025.02.007_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.644871","article-title":"Associations between Stevens-Johnson Syndrome and infection: overview of pharmacoepidemiological studies","volume":"8","author":"Imatoh","year":"2021","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.amjms.2025.02.007_bib0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-2295","article-title":"Long-term sequelae of Stevens-Johnson Syndrome\/toxic epidermal necrolysis","volume":"96","author":"Yang","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"18","key":"10.1016\/j.amjms.2025.02.007_bib0026","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/jcm10184287","article-title":"Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of the literature","volume":"10","author":"Jevtic","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.amjms.2025.02.007_bib0027","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.24748.1","article-title":"Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Hasegawa","year":"2020","journal-title":"F1000Res"},{"issue":"103","key":"10.1016\/j.amjms.2025.02.007_bib0028","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1038\/sj.ki.5001915","article-title":"Prevention of infectious complications in peritoneal dialysis: best demonstrated practices","author":"Bender","year":"2006","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"10.1016\/j.amjms.2025.02.007_bib0029","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.2011.1127","article-title":"Association of race and age with survival among patients undergoing dialysis","volume":"306","author":"Kucirka","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.amjms.2025.02.007_bib0030","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2105\/AJPH.2012.301103","article-title":"Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature","volume":"103","author":"Ruiz","year":"2013","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.amjms.2025.02.007_bib0031","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11113-008-9087-4","article-title":"The impact of salmon bias on the Hispanic mortality advantage: new evidence from Social Security data","volume":"27","author":"Turra","year":"2008","journal-title":"Popul Res Policy Rev"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296292500922X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296292500922X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:58Z","timestamp":1762082218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296292500922X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S000296292500922X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.02.007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}